TNON
Tenon Medical, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$3.72
−1.33%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 5.3M | 3.9M | 3.3M | 2.9M | 691.0K |
| Cost of Revenue | 1.8M | 1.6M | 1.6M | 1.7M | 1.3M |
| Gross Profit | 3.5M | 2.4M | 1.7M | 1.2M | (641.0K) |
| Operating Expenses | |||||
| R&D Expense | 1.9M | 2.1M | 2.6M | 3.2M | 2.8M |
| SG&A Expense | 14.1M | 13.0M | 12.9M | 13.8M | 15.3M |
| General & Admin Expense | 7.1M | 7.0M | 7.8M | 7.0M | 7.4M |
| Selling & Marketing Expense | 7.0M | 6.0M | 5.1M | 6.8M | 7.8M |
| Other Expenses | 544.0K | — | — | — | — |
| Total Operating Expenses | 16.5M | 15.2M | 15.5M | 17.0M | 18.1M |
| Cost and Expenses | 18.3M | 16.7M | 17.0M | 18.7M | 19.4M |
| Operating Income (EBIT) | (12.9M) | (12.8M) | (13.8M) | (15.7M) | (18.7M) |
| Non-Operating | |||||
| Interest Income | — | — | — | — | — |
| Interest Expense | 676.0K | — | 34.0K | 21.0K | 354.0K |
| Net Interest Income | (676.0K) | — | (34.0K) | (21.0K) | (354.0K) |
| Other Non-Op Income/Expense | (739.0K) | 236.0K | 93.0K | 146.0K | (192.0K) |
| Non-Operating Income (excl Interest) | 23.0K | (236.0K) | (127.0K) | (167.0K) | (162.0K) |
| EBT (Pre-Tax Income) | (13.7M) | (12.6M) | (13.7M) | (15.6M) | (18.9M) |
| Income Tax Expense | — | — | — | — | — |
| Bottom Line | |||||
| Net Income | (13.7M) | (12.6M) | (13.7M) | (15.6M) | (18.9M) |
| Earnings from Cont. Ops | (13.7M) | (12.6M) | (13.7M) | (15.6M) | (18.9M) |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | (13.7M) | (12.6M) | (13.7M) | (15.6M) | (18.9M) |
| Per Share | |||||
| Basic EPS | ($46.30) | ($59.50) | ($394.10) | ($2,402.40) | ($6,555.50) |
| Diluted EPS | ($46.30) | ($59.50) | ($394.10) | ($2,402.40) | ($6,555.50) |
| Revenue Per Share | $16.25 | $18.69 | $94.48 | $451.45 | $239.46 |
| Shares | |||||
| Basic Shares Outstanding | 328000 | 210971 | 34686 | 6486 | 2886 |
| Diluted Shares Outstanding | 328000 | 210971 | 34686 | 6486 | 2886 |
| Profitability Metrics | |||||
| EBITDA | (12.5M) | (12.0M) | (13.0M) | (15.1M) | (18.3M) |
| D&A | 462.0K | 530.0K | 655.0K | 426.0K | 289.0K |
| EBIT | (12.9M) | (12.6M) | (13.6M) | (15.6M) | (18.6M) |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026